Company intelligence / Profile preview

DynamiCure Biotech

Waltham, Massachusetts, United States
Ownership
Private
Employees
~50
Development stage
Other
01

Overview

DynamiCure Biotech is a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapies for cancer and autoimmune diseases. The company leverages its proprietary D-Leap platform to identify and target novel biological pathways, with a particular emphasis on the CD24 and CXCL13/CXCR5 axes. Its lead candidate, DCB-001, is a first-in-class monoclonal antibody targeting CD24 currently undergoing Phase 1 clinical trials for advanced solid tumors. DynamiCure operates with a global footprint, maintaining research and development facilities in both the United States and China to accelerate the delivery of transformative medicines to patients worldwide.

Therapeutic areas
OncologyImmunology
Modalities
Monoclonal antibodyAntibodyBispecific monoclonal antibody
Industry
Biotech
02

Drug pipeline

3 assets

DCSZ11

2

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on DynamiCure Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DynamiCure Biotech.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call